CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-20 | Buller Richard E Director | Sale | −300 | $7.34 | $2K | 8,525 |
| 2021-11-22 | Buller Richard E Director | Sale | −250 | $15.55 | $4K | 8,825 |
| 2021-11-19 | Buller Richard E Director | Sale | −250 | $16.15 | $4K | 9,075 |
| 2021-10-27 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +821 | 821 | ||
| 2021-10-27 | Laing Lance G. Chief Science Officer | Grant or award · Stock Option (right to buy) | +1,877 | 1,877 | ||
| 2021-10-27 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +6,569 | 6,569 | ||
| 2021-08-11 | Laing Lance G. Chief Science Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-08-11 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +17,000 | 17,000 | ||
| 2021-08-11 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-08-11 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-12 | NIGON RICHARD Director | Grant or award · Stock Option (right to buy) | +4,619 | 4,619 | ||
| 2021-05-12 | Furcht Leo Director | Grant or award · Stock Option (right to buy) | +4,619 | 4,619 | ||
| 2021-05-12 | Dalvey David Director | Grant or award | +1,482 | 9,325 | ||
| 2021-05-12 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +2,310 | 2,310 | ||
| 2021-05-12 | Buller Richard E Director | Grant or award | +1,482 | 9,325 | ||
| 2021-05-12 | Buller Richard E Director | Grant or award · Stock Option (right to buy) | +2,310 | 2,310 | ||
| 2021-04-12 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +3,806 | 3,806 | ||
| 2021-04-12 | Laing Lance G. Chief Science Officer | Grant or award · Stock Option (right to buy) | +6,754 | 6,754 | ||
| 2021-04-12 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +13,509 | 13,509 | ||
| 2021-03-18 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +1,204 | 1,204 |
Page 16 of 19 · 365 trades